Genfit Competitors and Similar CompaniesClear all
Genfit's competitors and similar companies include Ablynx, Promethera Biosciences, Roche and Esperite.
 Genfit GENFIT is a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions to address high unmet patient needs. |  Ablynx Ablynx is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments. |  Promethera Biosciences Promethera Biosciences is a healthcare company developing cell therapy technologies for chronic liver diseases. | |||
Founding Date | Founding Date 1999 | Founding Date 2001 | Founding Date 2009 | Founding Date 1896 | Founding Date 2000 |
Type | Type Public | Type Subsidiary | Type Subsidiary | Type Public | Type Public |
Tags | |||||
Locations | Locations Loos, FR HQ Cambridge, US | Locations Gent, BE HQ | Locations Mont-Saint-Guibert, BE HQ Charleroi, BE Ganshoren, BE Chuo City, JP Chuo City, JP Basel, CH Durham, US see more | Locations Amsterdam, NL HQ Villeurbanne, FR | |
Employees | Employees 180 | Employees 1252% decrease | Employees 185% decrease | Employees 103,249 | Employees 133 |
Valuation ($) | Valuation ($) 280.8 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 38.3 m |
Financial | |||||
Revenue (est.) | Revenue (est.) €65.4m (FY, 2025) | Revenue (est.) €85.2m (FY, 2016) | Revenue (est.) N/A | Revenue (est.) CHF61.5b (FY, 2025) | Revenue (est.) €11.8m (FY, 2018) |
Cost of goods | Cost of goods €302k (FY, 2025) | Cost of goods N/A | Cost of goods N/A | Cost of goods CHF13.1b (FY, 2025) | Cost of goods €4.3m (FY, 2018) |
Gross profit | Gross profit €70.8m (FY, 2025) | Gross profit N/A | Gross profit N/A | Gross profit CHF50.5b (FY, 2025) | Gross profit €7.5m (FY, 2018) |
Net income | Net income (€86m) (FY, 2025) | Net income (€1.1m) (FY, 2016) | Net income N/A | Net income CHF13.8b (FY, 2025) | Net income (€18.5m) (FY, 2018) |
Operating ⚠ | |||||
Patents (Foreign) | Patents (Foreign) 450 (FY, 2019) | Patents (Foreign) 180 (Q2, 2017) | Patents (Foreign) N/A | Patents (Foreign) N/A | Patents (Foreign) N/A |
Patents (US) | Patents (US) 28 (FY, 2019) | Patents (US) 50 (Q2, 2017) | Patents (US) N/A | Patents (US) N/A | Patents (US) N/A |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 498.8m | Total funding raised $ 146m | Total funding raised $ 7.8b | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Ablynx
HQ
Gent, BE
Ablynx is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments.
View companyPromethera Biosciences
HQ
Mont-Saint-Guibert, BE
Promethera Biosciences is a healthcare company developing cell therapy technologies for chronic liver diseases.
View company
Roche
HQ
Basel, CH
Employees
103,249
Roche Holding is a biotech company that provides in vitro diagnostics and supplies services.
View company
Esperite
HQ
Amsterdam, NL
Employees
133
Esperite is a company specializing in regenerative and predictive medicine.
View company